Примери за използване на Involved patients на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The experiment involved patients with long-term hypertension.
One of the studies was in patients aged over 12 years,while the other involved patients aged between six and 12 years.
Most studies involved patients with mild to moderate.
The first study involved previously untreated patients while the second study involved patients who had failed previous treatment.
Two studies involved patients who had not previously been treated for HIV.
It is noted that 23% of the hepatic cases reported for nimesulide involved patients treated for more chronic indications.
It involved patients who were already being treated for hypertension, but were not responding well to the medications.
Hypertension and one involved patients with severe hypertension.
It involved patients who had been treated at the University Hospital Basel, of whom 341 had received an allogeneic stem cell transplantation and 125, an autologous stem cell transplantation.
The Oslif Breezhaler Phase III clinical development programme involved patients with a clinical diagnosis of moderate to severe COPD.
The study involved patients with type 2 diabetes who already had cardiovascular disease(such as angina, heart attack and stroke).
Because Alli is based on another medicine containing the same active substance already authorised in the EU(Xenical 120 mg capsules),some of the studies involved patients who took Xenical.
Two of these studies involved patients who were starting treatment for anaemia.
This study involved patients with either wild-type or mutant RAS whose disease had got worse despite treatments that included a fluoropyrimidine, oxaliplatin and irinotecan.
The overall reports involved patients over the age of 65 in 22% of cases and patients aged 75 and over in 13% of cases.
The first two studies involved patients whose metastatic disease was being treated for the first time(‘first-line' treatment): in the first study(923 patients), the average overall survival was 20.3 months in patients adding Avastin and 15.6 months in those receiving chemotherapy alone; in the second study in 1,401 patients, progression-free survival was 9.4 months in patients adding Avastin and 8.0 months in those receiving chemotherapy alone.
The other three main studies involved patients with malignant glioma that had come back or got worse after previous treatment.
Most studies involved patients with mild to moderate hypertension and one involved patients with severe hypertension.
RADIANT-3 involved patients with well- and moderately-differentiated advanced pNET whose disease had progressed within the prior 12 months.
The short-term studies involved patients with major depressive episodes that had not responded to up to three previous antidepressant treatments.
The fifth study involved patients for whom a biological disease-modifying anti-rheumatic medicine was either not suitable or did not work well enough.
The first study involved patients undergoing surgery or a procedure under an anaesthetic block(where sensation to a part of the body is blocked).
The experiment involved patients receiving antibiotics in combination with probiotics, and the volunteers who took the antibiotic and placebo, that is a pacifier.
The second study involved patients undergoing a fibreoptic intubation(inserting a breathing tube through the nose or the mouth into the windpipe) while patients are awake.
In one of the studies, which involved patients with bone metastases from prostate cancer, the patients' use of opioid analgesics(such as morphine) was also reduced following treatment with QUADRAMET.
The second study involved patients with complicated urinary tract infection(including kidney infection), complicated intra-abdominal infections, lung infections caught in hospital and bacteraemia.
The clinical trial in CLL involved patients who had not received previous treatment, some of whom had the 17p deletion or TP53 mutation; however, it also investigated a combination of medicines which is currently not approved.
Two of these studies involved patients with glioblastoma multiforme: one looked at the effects of Temodal in 138 patients and the other compared Temodal with procarbazine(another anticancer medicine) in 225 patients. .
The first two studies involved patients whose metastatic disease was being treated for the first time(‘ first-line' treatment): the first study(923 patients) compared chemotherapy with and without Avastin, and the second(1,401 patients) compared adding Avastin with adding placebo(a dummy treatment).